**Core Concept:** Pilocarpine is a cholinergic agent that acts on the parasympathetic ocular system. In persons with closed angle glaucoma, increased aqueous humor production leads to elevated intraocular pressure (IOP), which contributes to the progression of glaucoma. Pilocarpine lowers IOP by stimulating the parasympathetic ocular system and inhibiting the release of aqueous humor.

**Why the Correct Answer is Right:** Pilocarpine works as a parasympathetic agonist, leading to the activation of M3 muscarinic receptors in the ciliary body. This activation inhibits the enzyme phosphodiesterase, which in turn elevates cyclic AMP levels. Increased cyclic AMP levels stimulate the enzyme adenyl cyclase, leading to increased cGMP production. Higher cGMP levels cause the aqueous humor outflow to be facilitated, hence decreasing intraocular pressure.

**Why Each Wrong Option is Incorrect:**

A. This option incorrectly suggests that pilocarpine increases IOP by stimulating the sympathetic system. However, as mentioned above, pilocarpine acts on the parasympathetic ocular system, not the sympathetic system.

B. This option incorrectly suggests that pilocarpine reduces IOP by inhibiting the release of aqueous humor. As explained above, pilocarpine actually stimulates the parasympathetic system and facilitates aqueous humor outflow, leading to IOP reduction.

C. This option incorrectly suggests that pilocarpine reduces IOP by stimulating the sympathetic system. Similar to option A, pilocarpine acts on the parasympathetic ocular system, not the sympathetic system.

D. This option incorrectly suggests that pilocarpine reduces IOP by inhibiting the enzymes phosphodiesterase and adenyl cyclase. As explained above, pilocarpine increases cGMP production by activating M3 muscarinic receptors and stimulating adenyl cyclase, leading to a decrease in IOP.

**Clinical Pearl:** Understanding the pharmacological actions of medications like pilocarpine is crucial for managing glaucoma patients. Glaucoma treatment typically involves medications that either lower IOP or increase aqueous humor outflow. In the case of pilocarpine, its actions on the parasympathetic ocular system and the subsequent decrease in IOP make it a valuable agent for managing glaucoma patients, especially in cases of open angle glaucoma where parasympathetic stimulation is beneficial.